prof.dr. MJ (Maarten) IJzerman

Biography

Maarten IJzerman (Dutch, Australian) is Dean of Erasmus School of Health Policy & Management and Professor of Cancer Health Services Research in Erasmus University. He also is (honorary) Professor in the Melbourne School of Population and Global Health and University of Melbourne Centre for Cancer Research. 

Maarten studied biomedical sciences (Radboud University Nijmegen, Faculty of Medical Sciences) and received his PhD in biomedical engineering (University of Twente, Faculty of Electrical Engineering).

In his research he takes a systems approach to health (technology) innovation and cancer management. He leads work in genomics enable precision oncology including improving cancer outcomes across the whole episode of care. Current initiatives aim to promote access to cancer care across the globe, with an emphasis on global health challenges and healthcare sustainability.  

Maarten is an INSEAD alumnus (International Directors Program, Singapore) and received certificates from University of York (Health Economics) and Colombia University (Corporate Finance) and serves as a non-executive board member in the non-profit sector.

Erasmus School of Health Policy & Management

Dean | Erasmus School of Health Policy & Management
Email
ijzerman@eshpm.eur.nl

Erasmus School of Health Policy & Management

Full professor | Health Services Management & Organisation (HSMO)
Email
ijzerman@eshpm.eur.nl

Work

  • Maarten IJzerman & Stefan Sleijfer (6 June 2024) - Neem duurzaamheid en personeelstekorten mee in het pakketbeheer
  • Maarten IJzerman (10 May 2022) - Will Australia be left behind in the cancer genomics revolution?
  • Maarten IJzerman & Sarah-Jane Dawson (15 February 2021) - Testing, testing, testing: Can blood tests help detect cancers early?
  • Maarten IJzerman (29 September 2020) - Nieuwe kankermedicijnen: eerst veiligheid, dan snel naar patiënten
  • Maarten IJzerman (12 June 2020) - Costly, fatal delays, new model shows
  • Maarten IJzerman (1 May 2020) - How has the temporary closure of BreastScreen affected GPs?
  • Maarten IJzerman & Jon D. Emery (30 April 2020) - Is a delayed cancer diagnosis a consequence of COVID-19?
  • Maarten IJzerman (18 May 2019) - Improving Australia’s health system beyond the election
  • Maarten IJzerman & Kim Dalziel (16 May 2019) - Improving Australia’s health system beyond the election
  • Maarten IJzerman (2 May 2019) - Controlling the costs of whole-genome sequencing in cancer care

Laboratorium Microbiologie

Start date approval
January 2023
End date approval
November 2025
Place
HENGELO
Description
Lid Raad van Toezicht

Erasmus Centrum voor Zorgbestuur b.v.

Start date approval
July 2023
End date approval
June 2026
Place
ROTTERDAM
Description
Lid Raad van Commissarisen ECZB b.v. namens de EUR

Erasmus Trust Fund

Start date approval
September 2023
End date approval
August 2026
Place
ROTTERDAM
Description
Lid Bestuur Erasmus Trust Fund

University of Melbourne

Start date approval
November 2023
End date approval
November 2026
Place
MELBOURNE
Description
Visiting professor honorary

Universiteit Twente

Start date approval
December 2023
End date approval
December 2024
Place
ENSCHEDE
Description
Gastregistratie

International Society for Pharmacoeconomics ISPOR

Start date approval
February 2024
End date approval
February 2027
Place
PHILADELPHIA
Description
Chair Health Sciences Policy Council

Erasmus Enterprise b.v.

Start date approval
May 2024
End date approval
May 2026
Place
ROTTERDAM
Description
Commissaris

Medical innovation

Level
master
Year Level
master
Year
2023
Course Code
BM02MBI

Thesis HCM

Level
master
Year Level
master
Year
2023
Course Code
GW4030MV

Compare @count study programme

  • @title

    • Duration: @duration
Compare study programmes